Key evaluationQuestionsGroup 2

earlyeffects

KEQ4. To what extent did the actions in the Plan meet the stated objectives/contribute to the intended outcomes of the Plan?

KEQ8. As a result of implementing the actions in the Plan, what is the evidence to indicate improvements in relation to the goals and Strategic Objectives?

Key messages

  • The Plan is functioning primarily as an authorising and strategic framework

    Its clearest effects are at the system level - shaping policy priorities, legitimising action, and providing a shared direction for the cancer control sector.

  • System-level influence is strong across multiple domains

    Two years into a 10-year reform agenda, the Plan's strongest influences are seen in improved national alignment and policy coherence, elevated attention to equity, strengthened collaboration across the sector, and the establishment of national infrastructure.

  • Elevation of equity is the most significant and consistently reported finding of the evaluation

    The Plan is shifting equity — particularly Aboriginal and Torres Strait Islander cancer outcomes — from a commitment dependent on individual champions toward a shared system-wide priority, moving beyond framing to actively resource Indigenous-led initiatives and partnerships.

  • Downstream changes at the service and patient level remain at an early stage and are not yet clearly evident

    Consumers reported the least visible change of any stakeholder group, suggesting that implementation and system-level reform have not yet translated into widespread, meaningful improvements in frontline experiences and outcomes.

  • Translating system-level gains into frontline impact is the defining challenge for the next phase

    There is broad but cautious optimism that current progress will lead to measurable population health impact over time, but extending the Plan's influence from policy and leadership circles to frontline services and community settings remains an important focus.

The Australian Cancer Plan is shaping system-level change

At the 2-year mark, the strongest effects are seen in influence, alignment and enabling conditions rather than direct service-level outcomes.

1. National alignment and policy coherence

The Plan is functioning as a shared national framework for cancer control.

It is shaping policy priorities, supporting alignment between jurisdictions and sectors, and giving organisations a common reference point for strategy, planning, investment and advocacy.

2. Elevation of equity

Equity has been elevated from a principle to a shared system-wide priority.

The Plan has strengthened visibility, legitimacy and resourcing for equity-focused action, particularly for Aboriginal and Torres Strait Islander cancer outcomes, and is supporting Indigenous-led initiatives and partnerships.

3. Strengthened collaboration

The Plan is catalysing new partnerships and strengthening existing ones.

Implementation partnerships, the ACCN and broader sector engagement are helping connect governments, cancer organisations, health services, researchers, consumers and priority population sectors around shared priorities.

4. National infrastructure

Foundational frameworks, platforms and system capabilities are now in place.

National initiatives such as the National Optimal Care Pathways Framework, National Framework for Genomics in Cancer Control, National Cancer Data Framework, the Australian Comprehensive Cancer Network and Improving First Nations Cancer Outcomes initiatives provide infrastructure to support implementation over the life of the Plan.

Together, these effects show that the Plan is operating as a national system stewardship mechanism. The next challenge is translating system-level gains into consistent frontline delivery, measurable outcomes and improved experiences for people affected by cancer.

Stronger national alignment and policy coherence

Since its launch in November 2023, the Plan has functioned primarily as an authorising and strategic framework, with its clearest effects at the system level — shaping policy priorities, legitimising action, and providing a shared direction for the cancer control sector.

“The Australian Cancer Plan acts as a framework that aligns with state and territory plans, setting strategic goals and concentrating national efforts on areas requiring coordinated action. Rather than duplicating existing plans, it complements them, leverages state initiatives, and prioritises national issues such as equity. Building on state and territory plans, it directs attention to where national coordination is most needed.” Union for International Cancer Control, 2026

For example, Chris O’Brien Lifehouse has explicitly aligned its organisational strategy and governance reporting to the Plan’s priorities, positioning its activities as contributing to national cancer control objectives. The Pancare Foundation has similarly aligned its organisational, research and advocacy strategies with the Plan’s strategic objectives. Cancer Council Australia has drawn on the Plan to inform policy and pre-budget submissions, using its priorities to frame national investment proposals. Ovarian Cancer Australia has also identified the Plan as an important influence on its strategic planning and service delivery direction. Sector alignment is expected to continue as implementation matures.

State and Territory Cancer Plans

State/ Territory

Current plan

Title/ status

Indigenous cancer plan

ACT

No plan underway

NT

In progress; anticipated 2026

NSW

NSW Cancer Plan 2022-2027. New plan also in progress

QLD

QLD Cancer Strategy 2024

SA

SA Cancer Plan 2025-2029

TAS

In progress; anticipated 2026

VIC

VIC Cancer Plan 2024-2028

WA

In progress; timing unknown

While the Plan is functioning effectively as a shared organising framework, stakeholders identified an opportunity to strengthen how it directs investment across government – with some noting that funding decisions across the grants landscape do not always reflect Plan priorities. Strengthening alignment between the Plan and broader investment mechanisms - across Commonwealth, state and territory, and non-government funding streams – is an opportunity for the next phase.

The six main pillars of the Australian Cancer Plan are mirrored in the six main pillars of the South Australian Cancer Plan. That alignment was done deliberately when the South Australian Cancer Plan was being written.
Jurisdictional stakeholder in consultation
The six main pillars of the Australian Cancer Plan are mirrored in the six main pillars of the South Australian Cancer Plan. That alignment was done deliberately when the South Australian Cancer Plan was being written.
Jurisdictional stakeholder in consultation
The Australian Cancer Plan was released during the consultation for the [development of the] current Victorian Cancer Plan. So there was certainly a lot of interest and engagement with what was happening with the Australian Cancer Plan so that we could align.
Jurisdictional stakeholder in consultation
We did develop a new plan in 2022, ready to go, but then the national cancer plan came out. So we delayed our strategy to reflect alignment with the cancer plan.
Jurisdictional stakeholder in consultation
We're guided by the Australian Cancer Plan as the pre-eminent document that guides the national approach to cancer control in Australia.
Commonwealth stakeholder in consultation
We sit at the nexus of Commonwealth and States and territories. Having these kinds of documents that have buy-in across governments is really useful to help us in promoting the kinds of data improvements and harmonisations that we try and do.
Commonwealth stakeholder in consultation
I think there's still sometimes a bit of a scattergun approach [to grants and funding]. How can this be used to bridge the gap between the different funding mechanisms?
Commonwealth stakeholder in consultation

Stronger national alignment and policy coherence

Since its launch in November 2023, the Plan has functioned primarily as an authorising and strategic framework, with its clearest effects at the system level — shaping policy priorities, legitimising action, and providing a shared direction for the cancer control sector.

“The Australian Cancer Plan acts as a framework that aligns with state and territory plans, setting strategic goals and concentrating national efforts on areas requiring coordinated action. Rather than duplicating existing plans, it complements them, leverages state initiatives, and prioritises national issues such as equity. Building on state and territory plans, it directs attention to where national coordination is most needed.” Union for International Cancer Control, 2026

For example, Chris O’Brien Lifehouse has explicitly aligned its organisational strategy and governance reporting to the Plan’s priorities, positioning its activities as contributing to national cancer control objectives. The Pancare Foundation has similarly aligned its organisational, research and advocacy strategies with the Plan’s strategic objectives. Cancer Council Australia has drawn on the Plan to inform policy and pre-budget submissions, using its priorities to frame national investment proposals. Ovarian Cancer Australia has also identified the Plan as an important influence on its strategic planning and service delivery direction. Sector alignment is expected to continue as implementation matures.

State and Territory Cancer Plans

State/ Territory

Current plan

Title/ status

Indigenous cancer plan

ACT

No plan underway

NT

In progress; anticipated 2026

NSW

NSW Cancer Plan 2022-2027. New plan also in progress

QLD

QLD Cancer Strategy 2024

SA

SA Cancer Plan 2025-2029

TAS

In progress; anticipated 2026

VIC

VIC Cancer Plan 2024-2028

WA

In progress; timing unknown

While the Plan is functioning effectively as a shared organising framework, stakeholders identified an opportunity to strengthen how it directs investment across government – with some noting that funding decisions across the grants landscape do not always reflect Plan priorities. Strengthening alignment between the Plan and broader investment mechanisms - across Commonwealth, state and territory, and non-government funding streams – is an opportunity for the next phase.

The six main pillars of the Australian Cancer Plan are mirrored in the six main pillars of the South Australian Cancer Plan. That alignment was done deliberately when the South Australian Cancer Plan was being written.
Jurisdictional stakeholder in consultation
The six main pillars of the Australian Cancer Plan are mirrored in the six main pillars of the South Australian Cancer Plan. That alignment was done deliberately when the South Australian Cancer Plan was being written.
Jurisdictional stakeholder in consultation
The Australian Cancer Plan was released during the consultation for the [development of the] current Victorian Cancer Plan. So there was certainly a lot of interest and engagement with what was happening with the Australian Cancer Plan so that we could align.
Jurisdictional stakeholder in consultation
We did develop a new plan in 2022, ready to go, but then the national cancer plan came out. So we delayed our strategy to reflect alignment with the cancer plan.
Jurisdictional stakeholder in consultation
We're guided by the Australian Cancer Plan as the pre-eminent document that guides the national approach to cancer control in Australia.
Commonwealth stakeholder in consultation
We sit at the nexus of Commonwealth and States and territories. Having these kinds of documents that have buy-in across governments is really useful to help us in promoting the kinds of data improvements and harmonisations that we try and do.
Commonwealth stakeholder in consultation
I think there's still sometimes a bit of a scattergun approach [to grants and funding]. How can this be used to bridge the gap between the different funding mechanisms?
Commonwealth stakeholder in consultation

Elevation of equity as a system-wide priority

The most significant and consistently reported finding of the evaluation is the Plan’s elevation of equity as a central system priority, particularly Aboriginal and Torres Strait Islander cancer outcomes and equity for priority populations more broadly. This has positioned equity as a shared responsibility and increased its visibility across policy, funding, workforce, research, and service planning.

The Plan provides a nationally endorsed rationale and shared mandate for organisations to prioritise equity in ways that were previously more difficult to sustain without explicit national direction. By explicitly identifying equity as central to success and embedding it across the entirety of the Plan, it has helped shift equity from an optional or peripheral consideration to an increasingly collectively legitimised priority across the system. Stakeholders emphasised that this is shifting equity from a commitment dependent on individual champions toward a broadly shared, institutionally reinforced priority.

Aboriginal and Torres Strait Islander stakeholders described this as both validating and transformative. The Plan has provided legitimacy, shared language, and permission for conversations that were previously more contested or difficult to sustain. Stakeholders noted this has enabled a more integrated view of Aboriginal and Torres Strait Islander cancer care across the full continuum — from prevention and screening through to treatment, survivorship, and palliative care.

Critically, this has extended beyond framing – the Plan has prioritised and actively resourced Indigenous-led initiatives and partnerships, including through the First Nations Cancer Scholarship Program, the Partnerships for Culturally Safe Cancer Care Grant Program and the refreshed OCP for Aboriginal and Torres Strait Islander People with Cancer. Early signals of the positive impact of some of these funded initiatives are already emerging, with stakeholders pointing to growing Indigenous leadership and research capacity, stronger workforce pipelines, and deepening partnerships between Aboriginal and Torres Strait Islander community-controlled organisations and mainstream cancer services.

Having a strategy that explicitly addresses equity and Aboriginal and Torres Strait Islander people is just a godsend — it now gives people a remit and things to do. It's really elevated the conversation and the action.
Aboriginal and Torres Strait Islander stakeholder in consultation
Having a strategy that explicitly addresses equity and Aboriginal and Torres Strait Islander people is just a godsend — it now gives people a remit and things to do. It's really elevated the conversation and the action.
Aboriginal and Torres Strait Islander stakeholder in consultation
Because it's in there, because there are certain things in there, it does shift things — the debate about getting something on the table is no longer there. It is now a matter of we have to deliver on the Australian Cancer Plan. And I think particularly in the Indigenous health space, that's where the conversation's really shifted.
Aboriginal and Torres Strait Islander stakeholder in consultation
When Cancer Australia says equity is now really important, it gives us all a licence to go — hey, look, this is now Australia's priority.
Cancer sector stakeholder (non-Aboriginal and Torres Strait Islander) in consultation
One of the things that I immediately did was go to the Australian Cancer Plan to understand what the expectation was for First Nations people and with that equity lens. That was really helpful — that information was very clear.
Jurisdictional stakeholder in consultation

Strengthened collaboration and partnerships

The Plan has catalysed new partnerships and strengthened existing ones, including across sectors beyond cancer control - mental health, disability, CALD communities, and Aboriginal and Torres Strait Islander health. Plan-enabled engagement beyond the cancer sector is influencing program design, resource allocation, and cross-disease collaboration, particularly around shared equity priorities that were previously fragmented.

The Implementation Partnership model and the ACCN were identified by stakeholders as key mechanisms supporting collaboration and partnerships. Collaboration has also extended into community settings through new multicultural and Indigenous partnerships. However, collaboration remains variable in depth and sustainability, and dependent in part on the availability of dedicated funding and formal partnership structures.

We're collaborating much more closely than we ever had before — across patient organisations and other sectors, with priority populations.
Cancer sector stakeholder in consultation
We're collaborating much more closely than we ever had before — across patient organisations and other sectors, with priority populations.
Cancer sector stakeholder in consultation
It's started to bring different components of cancer care together — what happened in the NGO space was over there, and what happened in government was over there. What the cancer plan has done is start to bring those together.
Cancer sector stakeholder in consultation
It's enabled conversations with health organisations that aren't in the cancer sector — especially around the priority population groups — creating conversations that may not otherwise have happened.
Cancer sector stakeholder in consultation

Establishment of national infrastructure

As detailed in Implementation progress (KEQ1), the Plan has established tangible national infrastructure — including frameworks, governance structures, partnerships, and system capabilities — that is expected to strengthen the foundations for delivery and accelerate progress toward its 5- and 10-year ambitions. Stakeholders consistently valued this infrastructure for enabling more connected, coordinated and nationally coherent cancer control, while identifying sustained investment and operationalisation at scale as the central challenge for the next phase.

The ACCN and other things that have come from Cancer Australia- reaching out to networks and engaging with the people at the coalface - has been really important and helps people like myself [in smaller jurisdictions] to feel included nationally.
Jurisdiction stakeholder in consultation
The ACCN and other things that have come from Cancer Australia- reaching out to networks and engaging with the people at the coalface - has been really important and helps people like myself [in smaller jurisdictions] to feel included nationally.
Jurisdiction stakeholder in consultation
Cancer Australia have done great work with the National Data Framework — those elements are really important to the work we're doing.
Cancer sector stakeholder in consultation
We've got fantastic frameworks and we've done all of the work on most of those 2-year actions, but now the rubber hits the road — how do we actually go from the frameworks and the system-setting pieces to implementation that reaches the potential the framework hopes it does?
Commonwealth stakeholder in consultation
The Data Framework is great, the Genomics Framework is good. The challenge is going to be to actually operationalise all of those and work out how that can be done nationally in a standardised, consistent fashion.
Jurisdictional stakeholder in consultation

Service and patient level change

Downstream changes at the service and patient level remain at an early stage and are not yet clearly evident. Consumers — the group the Plan ultimately serves — reported the least visible change of any stakeholder group. While broadly supportive of the Plan’s intent, consumer participants consistently distinguished between system-level activity and their lived experience, describing limited observable change in care delivery, low public awareness of the Plan, and inequities across cancer types, settings and population groups, drawing on their own lived experience and broader observations. This suggests a lag between system-level reform activity and consumer-visible change in experience and outcomes, consistent with what can reasonably be expected at this stage of a 10-year reform agenda, where system-level foundations typically precede measurable frontline change.

Stakeholders consistently identified a need to shift from system alignment toward implementation at scale — with clearer accountability, stronger delivery mechanisms, and more visible progress on equity and service improvement.

While there is strong support for the Plan and broad optimism that current system-level gains will translate into measurable population health impact over time, extending the Plan's influence from policy and leadership circles to frontline services and community settings will be an important focus for the next phase of implementation, consistent with stakeholder expectations regarding progression from system foundations to observable service-level impact.

I don't feel anything really at a system level in the hospitals. I don't see any change.
Consumer (person affected by cancer) in consultation
I don't feel anything really at a system level in the hospitals. I don't see any change.
Consumer (person affected by cancer) in consultation
People are talking about the Plan, but my experience as a patient hasn't really changed.
Consumer (person affected by cancer) in consultation
There's nothing quite tangible at a local level... it's really just an increase in discussion.
Consumer (person affected by cancer) in consultation
Hope and cynicism. That's how I feel about the Australian Cancer Plan.
Consumer (person affected by cancer) in consultation
Isn't yet getting runs on the ground, but it will.
Cancer sector stakeholder in consultation